512 related articles for article (PubMed ID: 8104241)
1. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
Bril A; Slivjak M; DiMartino MJ; Feuerstein GZ; Linee P; Poyser RH; Ruffolo RR; Smith EF
Cardiovasc Res; 1992 May; 26(5):518-25. PubMed ID: 1359930
[TBL] [Abstract][Full Text] [Related]
3. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
Yue TL; Cheng HY; Lysko PG; McKenna PJ; Feuerstein R; Gu JL; Lysko KA; Davis LL; Feuerstein G
J Pharmacol Exp Ther; 1992 Oct; 263(1):92-8. PubMed ID: 1357162
[TBL] [Abstract][Full Text] [Related]
4. Myocardial protection with carvedilol.
Feuerstein GZ; Hamburger SA; Smith EF; Bril A; Ruffolo RR
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S138-41. PubMed ID: 1378142
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective potential of carvedilol.
Ruffolo RR; Bril A; Feuerstein GZ
Cardiology; 1993; 82 Suppl 3():24-8. PubMed ID: 8106160
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol, a new beta-adrenoreceptor blocker, vasodilator and free-radical scavenger, exerts an anti-shock and endothelial protective effect in rat splanchnic ischemia and reperfusion.
Christopher TA; Lopez BL; Yue TL; Feuerstein GZ; Ruffolo RR; Ma XL
J Pharmacol Exp Ther; 1995 Apr; 273(1):64-71. PubMed ID: 7714814
[TBL] [Abstract][Full Text] [Related]
7. Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
Asanuma H; Minamino T; Sanada S; Takashima S; Ogita H; Ogai A; Asakura M; Liao Y; Asano Y; Shintani Y; Kim J; Shinozaki Y; Mori H; Node K; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Jun; 109(22):2773-9. PubMed ID: 15148268
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
Ruffolo RR; Feuerstein GZ
Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits.
Ma XL; Yue TL; Lopez BL; Barone FC; Christopher TA; Ruffolo RR; Feuerstein GZ
J Pharmacol Exp Ther; 1996 Apr; 277(1):128-36. PubMed ID: 8613909
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection.
Feuerstein GZ; Ruffolo RR
Eur Heart J; 1996 Apr; 17 Suppl B():24-9. PubMed ID: 8733068
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat.
Smith EF; Griswold DE; Hillegass LM; Slivjak MJ; Davis PA; DiMartino MJ
Pharmacology; 1992; 44(6):297-305. PubMed ID: 1354874
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotection by Carvedilol: antiapoptosis is independent of beta-adrenoceptor blockage in the rat heart.
Schwarz ER; Kersting PH; Reffelmann T; Meven DA; Al-Dashti R; Skobel EC; Klosterhalfen B; Hanrath P
J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):207-15. PubMed ID: 14506546
[TBL] [Abstract][Full Text] [Related]
13. Carvedilol treatment after myocardial infarct decreases cardiomyocytic apoptosis in the peri-infarct zone during cardioplegia-induced cardiac arrest.
Yeh CH; Chen TP; Wang YC; Lin YM; Fang SW
Shock; 2013 Apr; 39(4):343-52. PubMed ID: 23481492
[TBL] [Abstract][Full Text] [Related]
14. Preclinical and clinical pharmacology of carvedilol.
Ruffolo RR; Boyle DA; Venuti RP; Lukas MA
J Hum Hypertens; 1993 Feb; 7 Suppl 1():S2-15. PubMed ID: 8487245
[TBL] [Abstract][Full Text] [Related]
15. Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia.
Hashimoto H; Kanda A; Hubo H; Tanaka M
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S22-8. PubMed ID: 1721975
[TBL] [Abstract][Full Text] [Related]
16. Effects of carvedilol on left ventricular function and arrhythmias during repeated short-time myocardial ischemia in experimental pigs.
Höher M; Friedrich M; Sommer T; Marten A; Ehmer B; Hombach V; Hirche H
Z Kardiol; 1989; 78 Suppl 3():7-15. PubMed ID: 2573214
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of carvedilol in the myocardium.
Feuerstein GZ; Bril A; Ruffolo RR
Am J Cardiol; 1997 Dec; 80(11A):41L-45L. PubMed ID: 9412541
[TBL] [Abstract][Full Text] [Related]
18. Carvedilol (Kredex) reduces infarct size in a canine model of acute myocardial infarction.
Hamburger SA; Barone FC; Feuerstein GZ; Ruffolo RR
Pharmacology; 1991; 43(3):113-20. PubMed ID: 1685569
[TBL] [Abstract][Full Text] [Related]
19. Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model.
Gao F; Chen J; Lopez BL; Christopher TA; Gu J; Lysko P; Ruffolo RR; Ohlstein EH; Ma XL; Yue TL
Eur J Pharmacol; 2000 Oct; 406(1):109-16. PubMed ID: 11011041
[TBL] [Abstract][Full Text] [Related]
20. Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils.
Yue TL; McKenna PJ; Ruffolo RR; Feuerstein G
Eur J Pharmacol; 1992 Apr; 214(2-3):277-80. PubMed ID: 1355437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
